Zymeworks Competitors and Similar CompaniesClear all
Coherus BioSciences's competitors and similar companies include Foghorn Therapeutics.
 Coherus BioSciences Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. |  Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. | |
Founding Date | Founding Date 2010 | Founding Date 2016 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Redwood City, US HQ Camarillo, US | Locations Cambridge, US HQ Cambridge, US |
Employees | Employees 30615% decrease | Employees 16135% increase |
Valuation ($) | Valuation ($) 85.6 m | Valuation ($) 452 m |
Financial | ||
Revenue (est.) | Revenue (est.) $257.2m (FY, 2023) | Revenue (est.) $34.2m (FY, 2023) |
Net income | Net income ($237.9m) (FY, 2023) | Net income ($98.4m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 174.5m | Total funding raised $ 50m |
For sources of this data, please see the company profile
View Company Profiles
Foghorn Therapeutics
HQ
Cambridge, US
Employees
161↑ 35% increase
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
View company